This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Teknova, a producer of lifesciencereagents, has opened a new GMP-certified production facility which it claims will enable bioprocessing and gene therapy companies to get into the clinic faster.
The deal will see Polyplus join the German lifescience group’s portfolio allowing the latter to leverage expertise in transfection reagents and plasmid DNA for gene therapy. Polyplus, based in Strasbourg, France, produces key components in the production of viral vectors used in cell and gene therapies.
Illumina , the world’s leading DNA sequencing and array-based technologies company, is partnering with Sequoia Capital China, an investment firm, to launch a lifesciences incubator in China. The focus will be on building lifescience startups specializing in genomics.
The FDA’s General Approach to Regulating mHealth Products. Although mHealth has been gaining in popularity for at least the past decade, before commercializing their mHealth products, developers must determine whether the product is subject to U.S. General Wellness Products. Mobile Medical Applications.
With this acquisition, Calibre Scientific bolsters its strength in the chromatography market and continues to broaden its lifesciences presence in Europe. With the acquisition of AIT, Calibre Scientific gains a strategic partner to continue its growth in lifesciences. About Calibre Scientific.
Source link.
An ACR urine reagent dipstick/strip. An absorbent pad to remove excess liquid from the reagent strip. The reagent strip is dipped into the urine sample for one second and any excess liquid is removed using the absorbent pad. A color board that allows for image recognition. “Healthy.io in the company’s press release.
The Toronto-based company already counts many of the world’s largest pharma companies among its customers, using its platform for a range of tasks such as improving reagent and antibody selection to help scientists run more successful experiments, drawing on data from published studies and organisations’ internal databases.
The company creation engine will focus on building lifesciences startup companies advancing breakthrough applications in genomics. Our products are used for applications in the lifesciences, oncology, reproductive health, agriculture, and other emerging segments.
Access to laboratory reagents, equipment and research subjects is a necessity for researchers to complete their experimental work, as well as care for live cells, plants or animals. To keep these workers safe, employers have implemented social distancing protocols in the workplace, for employees and customers alike.
Chemical, reagent and sample transportation add another layer of complexity, particularly when specific storage conditions must be maintained before, during and after the move. Lab relocation and downsizing will always be challenging but it doesn’t have to result in extended periods of downtime, equipment inefficiencies and lost productivity.
The growing interest of spatial omics solutions providers to diversify their products portfolio and enhance the abilities of their existing instruments, has led to several deals inked for the integration of spatial omics solutions with the contemporary staining assays / reagents.
This could involve tweaking experimental conditions, changing reagents or redesigning the assay. For example, biochemical assays or medical devices are subject to certain good manufacturing practice (GMP) compliance standards, which can be industry- and product-specific.
When you consider the existing challenges limiting the upstream production of viral vectors, this figure becomes even more alarming. Better transfection reagents and efforts to automate the currently highly manual and inconsistent process could also make a difference, he adds.
Moreover, Dr. Lin explains that in an academic lab, you are supposed to do everything – from ordering reagents, to washing dishes to doing an in vitro study for a project and then the in vivo work, through to completion. On the other hand, industry can also learn from academia in terms of “just the love of pure science,” she says. “I
Instead of RNA extraction, the Yale test involves use of a reagent that when mixed with a saliva sample and heated for a short period of time, releases the viral genome for subsequent detection with PCR. Having a test that requires less reagents and resources, such as the RNA extraction kits, increases capabilities for increased testing.
She is also a board member at BBI Solutions, a UK based diagnostic reagents and a Novo Holdings company. Karen will be Vice Chair of the future Board of Directors of Sandoz as well as the ad interim Chair of its Science, Innovation & Development Committee. Urs will be Chair of the Human Capital & ESG Committee of Sandoz.
Since its founding in 2019, Invizyne has focused on developing SimplePath for essential chemical production. SimplePath’s approach enables near-theoretical yields, where most input material converts into the desired product with minimal waste. billion global SAF market projected by 2032.
The result was a prepackaged, off-the-shelf reagent kit that provided reliable quantification for a wide variety of influenza mRNA vaccine constructs. This approach ensured that the assay could balance specificity with sensitivity, even when faced with diverse construct sequences.
Medical device manufacturers are leveraging these technologies to enhance their products, supporting healthcare providers and improving patient outcomes. This reduces human error and contamination risks, ensuring higher-quality production outcomes. The global next-generation biomanufacturing market is projected to grow at a CAGR of 14.85
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content